Value and limitations of colloidal systems in ophthalmology;Les vecteurs colloïdaux: Intérêts et limites en ophtalmologie

S.T.P. Pharma Pratiques

Volumn 12, Issue 1, 2002, Pages 42-49

  Bochot, A ^a   Barbault Foucher, S ^a   Fattal, E ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Colloidal systems; Eye; Instillation; Intravitreous injection; Liposomes; Nanoparticles

Indexed keywords

ACICLOVIR; ADRENALIN; AGENTS ACTING ON THE EYE; AMIKACIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIMETABOLITE; ANTIVIRUS AGENT; ATROPINE; CIDOFOVIR; CIPROFLOXACIN; CLINDAMYCIN; CYCLOSPORIN; CYTARABINE; DEXAMETHASONE 17 VALERATE; DIHYDROSTREPTOMYCIN; DRUG CARRIER; FLUOROURACIL; GENTAMICIN; IDOXURIDINE; LIPOSOME; NANOPARTICLE; OLIGONUCLEOTIDE; PENICILLIN G; TACROLIMUS; TOBRAMYCIN; TRIAMCINOLONE ACETONIDE; UNINDEXED DRUG; VANCOMYCIN;

COLLOID; CONTROLLED DRUG RELEASE; CYTOMEGALOVIRUS; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG HALF LIFE; DRUG INDUCED DISEASE; DRUG SCREENING; DRUG SOLUTION; ENCAPSULATION; EYE DISEASE; HUMAN; PARTICLE SIZE; RETINITIS; REVIEW;

EID: 0036224958     PISSN: 11571497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Lachrymal and instilled fluid dynamics in rabbit eyes
2. Tear flow in normal human eyes. Determination by means of radioisotope and gamma camera scintigraphy
3. Altered bioavailability of drugs in the eye due to drug-protein interaction
4. Pharmacokinetics in ocular drug delivery
5. Epithélium et médicaments
6. Improved corneal penetration of timolol by prodrugs as a mean to reduce systemic drug load
7. Penetration routes of topically applied eye medications
8. Treatment of cytomegalovirus retinitis with intravitreal ganciclovir: Long term results
9. Liposomes en ophtalmologie
10. Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome
11. Treatment of cytomegalovirus retinitis
12. Use of intravitreal ganciclovir (dihydroxy propoxymethylguanine) for cytomegalovirus retinitis in a patient with AIDS
13. Advances in antiviral therapy for cytomegalovirus retinitis
14. Intravitreal pharmacokinetics of liposome-encapsulated amikacin in a rabbit model
15. Méthodes de préparation des lipsomes
16. Nanoparticles as drug delivery systems
17. Idoxuridine-liposome therapy for herpes simplex keratitis
18. Liposomal ophthalmic drug delivery system. II. Dihydrostreptomycin sulfate
19. Ocular distribution of liposomes encapsulated epinephrin and insulin in the albinos rabbit
20. Liposomal ophthalmic drug delivery. III. Pharmacodynamic and biodisposition studies of atropine
21. Comparison of the ocular distribution of a model oligonucleotide after topical instillation in rabbits of conventional and new dosage forms
22. A preliminary study of corneal penetration of 1251-labelled idoxuridine liposome
23. In-vivo studies on dexamethasone sodium phosphate liposomes
24. Liposomes in topical drug delivery
25. Liposome ophthalmic drug delivery system. I. Triamcinolone acetonide
26. Efficacy of a liposome preparation of anti-inflammatory steroid as an ocular drug-delivery system
27. Assessment of ocular irritability of liposomes preparations
28. Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye
29. Ocular absorption of ciclosporine A from liposomes incorporated into collagen shields
30. A gamma scintigraphic evaluation of the precorneal residence of liposomal formulations in the rabbit
31. Targeting of drugs loaded immunoliposomes to herpes simplex virus infected corneal cells: An effective means of inhibiting virus replication in vitro
32. Inhibition of herpes simplex virus replication in the mouse cornea by drug containing immunoliposomes
33. Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins
34. Liposomes and tear fluid. I. Release of vesicle-entrapped carboxyfluorescein
35. A gamma scintigraphic evaluation of microparticulate ophthalmic delivery systems: Liposomes and nanoparticles
36. Evaluation of mucoadhesive polymers in ocular drug delivery. II. Polymer-coated vesicles
37. Ocular disposition of polyhexyl-2-cyano[3-14C]acrylate nanoparticles in the albino rabbit
38. Design of new formulations for topical ocular administration: Polymeric nanocapsules containing metipranolol
39. Poly(epsiloncaprolactone) nanocapsules in carteolol ophtalmic delivery
40. Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drugs carriers
41. Polyester nanocapsules as new topical ocular delivery systems for ciclosporin A
42. Chitosan nanoparticles: A new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A
43. Studies on the transport pathway of PBCA nanoparticles in ocular tissues
44. Study of the mechanism of interaction of poly(-caprolactone) nanocapsules with the cornea by confocal laser scanning microscopy
45. Antiglaucomatous activity of betaxolol chlorhydrate sorbed onto different isobutylcyanoacrylate nanoparticle preparations
46. Colloidal drug delivery systems for the eye. A different polymers:polyisobutylcyanoacrylate, polylactic-co-glycolic acid, polyepsilon-caprolacton
47. Intravitreal administration of antisense oligonucleotides: Potential of liposomal delivery
48. Release kinetics of liposome-encapsulated ganciclovir after intravitreal injection in rabbits
49. Intravitreal delivery of oligonucleotides by sterically stabilized liposomes
50. Treatment of cytomegalovirus retinitis with intravitreal injection of liposome encapsulated ganciclovir in a patient with AIDS
51. Long-term therapy for herpes retinitis in an animal model with high-concentrated liposome-encapsulated HPMPC
52. Ocular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats